These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 24188277)
1. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis. Johnson MD; O'Connell MJ; Walter K BMC Complement Altern Med; 2013 Nov; 13():303. PubMed ID: 24188277 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3. Johnson MD; O'Connell M; Facik M; Maurer P; Jahromi B; Pilcher W J Neurooncol; 2012 Mar; 107(1):121-31. PubMed ID: 21971737 [TBL] [Abstract][Full Text] [Related]
3. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism. Johnson MD; O'Connell M; Pilcher W J Neurooncol; 2011 Feb; 101(3):441-8. PubMed ID: 20596751 [TBL] [Abstract][Full Text] [Related]
4. MKP-3 regulates PDGF-BB effects and MAPK activation in meningioma cells. Johnson MD; Reeder JE; O'Connell M J Clin Neurosci; 2015 Apr; 22(4):752-7. PubMed ID: 25698542 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. Johnson MD; O'Connell MJ; Pilcher W; Reeder JE J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046 [TBL] [Abstract][Full Text] [Related]
6. CIP2A and PP2A in human leptomeninges, arachnoid granulations and meningiomas. Johnson MD; Reeder JE; O'Connell M; Woodford M; Walter K J Clin Neurosci; 2014 Dec; 21(12):2228-32. PubMed ID: 25012485 [TBL] [Abstract][Full Text] [Related]
7. Radiation effects on human leptomeningeal cell response to cerebrospinal fluid and PDGF-BB. Johnson MD; O'Connell M; Iqbal MA; Williams JP Int J Radiat Biol; 2012 Jul; 88(7):547-55. PubMed ID: 22563889 [TBL] [Abstract][Full Text] [Related]
8. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas. Johnson MD; O'Connell M; Vito F; Bakos RS J Neurooncol; 2009 Apr; 92(2):129-36. PubMed ID: 19034385 [TBL] [Abstract][Full Text] [Related]
9. p38MAPK activation and DUSP10 expression in meningiomas. Johnson MD; Reeder JE; O'Connell M J Clin Neurosci; 2016 Aug; 30():110-114. PubMed ID: 27050915 [TBL] [Abstract][Full Text] [Related]
10. Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells. Johnson MD; Okedli E; Woodard A; Toms SA; Allen GS J Neurosurg; 2002 Sep; 97(3):668-75. PubMed ID: 12296652 [TBL] [Abstract][Full Text] [Related]
11. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. Johnson MD; Woodard A; Okediji EJ; Toms SA; Allen GS J Neurooncol; 2002 Jan; 56(2):133-42. PubMed ID: 11995814 [TBL] [Abstract][Full Text] [Related]
12. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro. Pfister C; Pfrommer H; Tatagiba MS; Roser F Br J Cancer; 2012 Nov; 107(10):1702-13. PubMed ID: 23047550 [TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line. Üremiş N; Üremiş MM; Çiğremiş Y; Tosun E; Baysar A; Türköz Y J Food Biochem; 2022 Oct; 46(10):e14333. PubMed ID: 35866877 [TBL] [Abstract][Full Text] [Related]
15. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Mei Y; Du Z; Hu C; Greenwald NF; Abedalthagafi M; Agar NYR; Dunn GP; Bi WL; Santagata S; Dunn IF Cell Commun Signal; 2017 Sep; 15(1):34. PubMed ID: 28923059 [TBL] [Abstract][Full Text] [Related]
16. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187 [TBL] [Abstract][Full Text] [Related]
18. Expression of the JAK and STAT superfamilies in human meningiomas. Magrassi L; De-Fraja C; Conti L; Butti G; Infuso L; Govoni S; Cattaneo E J Neurosurg; 1999 Sep; 91(3):440-6. PubMed ID: 10470819 [TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway. Ni Y; Wu S; Wang X; Zhu G; Chen X; Ding Y; Jiang W J Cell Biochem; 2018 Jul; 119(7):6104-6112. PubMed ID: 29575175 [TBL] [Abstract][Full Text] [Related]
20. Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide. Spear SA; Burns SS; Oblinger JL; Ren Y; Pan L; Kinghorn AD; Welling DB; Chang LS Otol Neurotol; 2013 Oct; 34(8):1519-27. PubMed ID: 23928514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]